- About Mesothelioma
- Mesothelioma Cause
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
Onconase is a specialized enzyme found originally in frogs that speeds up the an enzyme that specializes in the break down of RNA which in turn can destroy a cell or stop it from dividing.
It is now being investigated as a possible treatment to certain cancers, including mesothelioma.
Par Phamaceuticals buys licensing rights for malignant mesothelioma drug Onconase from Alfacell
Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
Onconase Potential as Chemopreventive Agent in Mesothelioma
U.S. Orphan Drug Designation for Onconase for Treatment of Malignant Mesothelioma
ONCONASE Shows Survival Benefit in Patients with Malignant Mesothelioma
Onconase Clinical Trial Enrollment Expected to Be Ahead of Schedule
Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
U.S. Orphan Drug Designation for Onconase applied for
Researchers Identify Intracellular Pathway of Onconase
Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
Managing your medications as a mesothelioma patient.
Note: Onconase is the brand name for ranpirnase.
Contact Us
News
- Mesothelioma News
- International News
- Pharmaceutical News
- Environmental News
- Medical Journal Articles
Resources
- Leading Cancer Links
- Financial Assistance, Compensation, and Legal Rights
- Disclaimer and Sponsorship Information
If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:
Toll-Free 1-877-367-6376

